Yuhan Corporation (KRX:000105)

South Korea · Delayed Price · Currency is KRW

70,300

+300 (0.43%)

Oct 23, 2026, 3:15 PM KST

Market Cap	6.32T -28.7%
Revenue (ttm)	2.28T +5.4%
Net Income	234.09B +195.3%
EPS	3,139.61 +193.3%
Shares Out	n/a
PE Ratio	22.39
Forward PE	40.28
Dividend	610.00 (0.87%)
Ex-Dividend Date	Feb 26, 2026

Volume	1,192
Open	70,650
Previous Close	70,000
Day's Range	69,400 - 71,200
52-Week Range	55,100 - 115,300
Beta	0.43
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1926

Employees 2,082

Stock Exchange Korea Stock Exchange

Ticker Symbol 000105

Financial Performance

In 2025, Yuhan's revenue was 2.19 trillion, an increase of 5.75% compared to the previous year's 2.07 trillion. Earnings were 191.09 billion, an increase of 170.33%.

Financial Statements